david

Big, scary stock market sell-offs happen all the … – Business Insider

The markets have been getting rocked this week.Stocks in the US were lower for a fourth day on Friday following Thursday’s brutal sell-off. The Dow was down as much as 291 points Friday with all 30 Dow stocks lower.  The S&P 500 briefly dropped below 2,000 for the first time since February (all of it sectors were in the red).Friday’s intra-day low of 1,993 […]

Goldman Sachs on sideways stock market – Business Insider

Bharat RanjanGoldman Sachs’ chief equity strategist David Kostin doesn’t think stocks are going anywhere for the rest of the year. In a note to clients over the weekend, Kostin and his team outlined 4 main reasons why the S&P 500 probably won’t do much of anything for the rest of the year and finish at 2,100. On Monday morning, futures were indicating […]

Don’t Forget These 5 Advantages You Hold Over Professional Investors

Written byJae Junfollow me onFacebookTwitter5 Common Excuses that Investors Believe 
The Uniqueness of the Stock Market
1. As a Small Investor You Are Able to Choose Your Expertise
2. You Can Go Against the Grain
3. You Are Not Judged Monthly, Quarterly or Yearly
4. You Can Afford to Be Patient
5. It’s Cheaper
Take Advantage of Your Advantages
“Don’t bother. The professionals are better than you and […]

A few big winners keep U.S. stock market afloat in 2015 – Business …

Thomson ReutersTraders work on the floor of the New York Stock Exchange shortly after the opening bell in New York(Reuters) – Amazon’s stock price surge into Friday made it the latest of a series of companies to boom following results, and its performance this year, along with a few others, has basically kept the S&P 500 above water.Data from S&P […]

Here's one way to sniff out a bubble within the stock market

It’s hard to spot an asset price bubble, especially if you’re in the midst of one. Usually, people find out they’re in a bubble only after it bursts.Goldman Sachs’ David Kostin offers this interesting stock market chart in a new note to clients. It’s a favorite of his.It shows the sector composition of the S&P 500 by market cap since […]

Stock market complacency is back – Business Insider

More Charts

Market complacency has re-emerged, warns Deutsche Bank’s David Bianco.His preferred measure of this is the PE / VIX ratio. (PE is short for price-earnings, a measure of stock market value. The VIX is the CBOE volatility index, a rough measure of “fear” in the stock market.)From Bianco’s note: “Our PE/VIX market emotion indicator climbed to 1.3 on S&P trailing […]

The problem with stock market charts – Business Insider

David W. Bianchi, “Blue Chip Kids”
May 13, 2015, 3:38 PM
4,162

When I was in college I took an economics class where the professor put up a chart showing the historical price movement of the Dow Jones Industrial Average.He then put up another chart that looked almost identical to the first one. Every time the Dow went up the other chart went […]

Manic-Selling Becomes Panic-Buying In Global Bond, Stock Markets

Overnight “manic-selling” in global bond markets (and turmoil in stock markets) has been met – suddenly – this morning by “panic-buying” as mysteriously liquid buyers lift stocks back into the green and send bond yields plunging (right after Euronext breaks)…Europe…And US…As Bloomberg adds,

“At some point the stress on stocks, risk assets, from either earnings fears or higher rates surely has […]

Big chance to buy biotech?

In fact, biotech stocks have been so strong that “you could see these stocks off another 10 percent from here, and still be in an uptrend,” Johnson said. “We’d be buying these names on the pullback.”The fundamentals also remain supportive of biotech, says David Seaburg, head of equity sales trading with Cowen & Co.”From a valuation perspective, this is not […]

Why the biotech rally could continue

Trading Nation: How hot can biotech get?
David Seaburg, Cowen & Co., and Ari Wald, Oppenheimer, join “Power Lunch” to discuss the biotech rally.
Biotech stocks have been on fire. The industry has risen 40 percent in the past year, and added 2.3 percent on Friday alone. This after drug giant Biogen reported positive results for a new Alzheimer’s drug, leading its […]